SCULLY WILLIAM P purchased $1.2M of PRTA
SCULLY WILLIAM P purchased 140,000 shares of PROTHENA CORP PUBLIC LTD CO (PRTA) at $8.53 ($1.19M total) on 2026-11-09.
How this was made
The 30-second read
Why it matters
The disclosed purchase adds a modest positive signal for PRTA, but the overall market impact is limited.
Market read
Insider buying in a micro‑cap can attract short‑term interest, but the modest size limits broader market relevance.
What to watch
Potential upcoming dilution or financing events that may offset the insider's confidence.
Background
Form 4 filings provide the first public disclosure of insider trades, offering fresh data for traders.
Ticker impact
SEC Form 4 shows insider William Scully purchased 140,000 shares for $1.19M, increasing his stake to 977,000 shares.
likely modest buying pressure as market prices in the insider stake increase
The purchase is sizable for a micro‑cap and comes from a 10% owner, suggesting confidence, but the dollar amount is modest.
Market effects
None significant; insider activity is company‑specific.
Limited to investors tracking micro‑cap insider moves.
Low
Counterpoint
The purchase could be a routine portfolio rebalancing rather than a bullish signal.
Key entities
- CompanyProthena Corp Public Ltd Co
Biotech firm listed on NASDAQ under ticker PRTA.
- InsiderWilliam Scully
10% owner of Prothena who made the purchase.
